Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
raleigh-durham blog main
4
×
raleigh-durham top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
deals
eli lilly
medicaid
medicare
startups
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
alder biopharmaceutical
aldeyra therapeutics
What
year
4
×
drug
companies
drugs
new
plan
price
therapies
adds
alliance
alzheimer’s
answer
approval
areas
arguments
away
big
bio
biosciences
bio’s
brii
class
commercialized
competitors
decades
democratic
dems
different
discontent
disease
earlier
election
fail
fda
gene
hepatitis
high
house
increases
infectious
Language
unset
Current search:
year
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline